Skip to main content

BIO-RAD LABORATORIES, INC.

corporate_fare Company Profile

BIO-RAD LABORATORIES, INC.

BIO·NYSE·Industrial Applications And Services·CIK 0000012208

Bio-Rad Laboratories, Inc. is a multinational life science and clinical diagnostics company that develops, manufactures, and markets a broad portfolio of instruments, systems, reagents, and consumables. The company has direct operations in over 36 countries outside the United States, with sales efforts supplemented by distributors and agents in certain locations. Bio-Rad operates in two industry segments: Life Science and Clinical Diagnostics, both operating worldwide. For the year ended December 31, 2025, the Life Science segment generated approximately 40% of consolidated net sales, and the Clinical Diagnostics segment generated approximately 60%. Approximately 40% of consolidated net sales for the year ended December 31, 2025, came from the U.S., and approximately 60% from international locations, with Europe being the largest international region. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials such as cells, proteins, and nucleic acids. These products are utilized in research and biopharmaceutical laboratory environments, biopharmaceutical manufacturing, quality control processes, food safety testing, and science education applications. This segment serves the research market, supporting scientific discovery from early research through clinical and applied use, offering thousands of life science products globally. The estimated worldwide sales of products in the markets served by this segment are approximately $19 billion. Principal customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, and food producers and testing laboratories. The Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market.

BIO-RAD LABORATORIES, INC. (NYSE:BIO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BIO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Activist Investor Elliott Plans Push to Boost Bio-Rad Stock, Sources Say
  • Bio-Rad Reports Steep Q1 Net Loss of $527.1M, EPS Plunges to ($19.55)
  • Stockholders Approve Amended Incentive Plan, Authorizing 335,000 Additional Shares
  • Shareholders to Vote on Equity Plan Expansion and Dual-Class Structure Challenge
  • Bio-Rad Updates Sartorius AG Financials Following 10-K Disclosure

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.58B
Net Income
$759.9M
Diluted EPS
$27.85
Op. Cash Flow
$532.2M
Free Cash Flow
$374.6M
Gross Profit
$1.34B
Operating Income
$47.2M
Cash & Equivalents
$529.8M
Total Debt
$1.2B
Debt / Equity
0.16×
Net Margin
29.4%
Shares Outstanding
27.26M sh
Source: 10-K · filed 2026-02-13 · accession 0000012208-26-000010
Browse all tickers starting with B →
$285.94
52-week range · as of 2026-04-24 $211.43 – $343.12
Market cap
$7.7B
Volume
184.4K (0.4× avg)
3-mo avg 461.6K
Live data · 2026-06-14 06:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BIO - Latest Insights

BIO
May 17, 2026, 8:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $247.53
Real-time Price: $285.94 info
Change: +$38.41 (+16%) info
Market Cap: $7.698B info
BIO
Apr 30, 2026, 4:31 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $280.12
Real-time Price: $285.94 info
Change: +$5.82 (+2%) info
Market Cap: $7.698B info
BIO
Apr 24, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $287.84
Real-time Price: $285.94 info
Change: -$1.90 (-0.66%) info
Market Cap: $7.698B info
BIO
Mar 25, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $273.60
Real-time Price: $285.94 info
Change: +$12.34 (+5%) info
Market Cap: $7.698B info
BIO
Feb 19, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $271.90
Real-time Price: $285.94 info
Change: +$14.04 (+5%) info
Market Cap: $7.698B info
BIO
Feb 12, 2026, 9:50 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $255.00
Real-time Price: $285.94 info
Change: +$30.94 (+12%) info
Market Cap: $7.698B info
BIO
Feb 12, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $292.42
Real-time Price: $285.94 info
Change: -$6.48 (-2%) info
Market Cap: $7.698B info